ANDA 83808, held by Contract Pharmacal. Quinidine Sulfate.
As of Nov 16, 2026, ANDA 83808 (Quinidine Sulfate), held by Contract Pharmacal, was first approved by FDA on Feb 14, 1977, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 14, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate200MG ยท tablet;oral | Quinidine Sulfate | Discontinued |
| Oct 13, 1989 | Supplement 21Labeling | Approved | None posted |
| Dec 19, 1988 | Supplement 19Manufacturing | Approved | None posted |
| Sep 20, 1988 | Supplement 20Manufacturing | Approved | None posted |
| Dec 19, 1985 | Supplement 18Manufacturing | Approved | None posted |
| Aug 2, 1985 | Supplement 16Manufacturing | Approved | None posted |
| Aug 2, 1985 | Supplement 17Manufacturing | Approved | None posted |
| May 15, 1985 | Supplement 14Manufacturing | Approved | None posted |
| May 15, 1985 | Supplement 15Manufacturing | Approved | None posted |
| Feb 14, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters